Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Fanny Franchini

6PUBLICATIONS
20CO-AUTHORS
Cross-sectional analysisCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Wastewater treatment processesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Dec 28, 2024
Toward value-based care using cost mining: cost aggregation and visualization across the entire colorectal cancer patient pathway.

Maura Leusder, Sven Relijveld, Derya Demirtas

|Dec 10, 2024
Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.

Bishma Jayathilaka, Farah Mian, Fanny Franchini

|Nov 03, 2024
Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.

Bishma Jayathilaka, Farah Mian, Fanny Franchini

|Sep 20, 2024
Leveraging the potential for deintensification in cancer care.

Jennifer A Soon, Fanny Franchini, Maarten J IJzerman

|Feb 10, 2021
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.

Koen Degeling, Nancy N Baxter, Jon Emery

|Aug 15, 2020
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy.

Jae Hong Im, Jon N Buzzelli, Keaton Jones

Pageof 1

Frequent Collaborators

2 joint publications

Jon Emery

2 joint publications

Peter Gibbs

2 joint publications

Bishma Jayathilaka

2 joint publications

Grant McArthur

2 joint publications

Maarten J IJzerman

1 joint publications

Alex Gordon-Weeks

1 joint publications

Jianzhou Chen

1 joint publications

Ruth J Muschel

1 joint publications

Koen Degeling

1 joint publications

Nancy N Baxter

Frequent Collaborators

2 joint publications

Jon Emery

2 joint publications

Peter Gibbs

2 joint publications

Bishma Jayathilaka

2 joint publications

Grant McArthur

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

177
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on : Mar 07, 2025

296
See more related videos

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

177
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.7K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on : Mar 07, 2025

296
See more related videos